Select Medical Holdings Corporation

SEM • Medical - Care Facilities

$16.51

▼ -0.01 (-0.09%)

Current price

EarningsLatest report: Mar 31, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$2.04B

Growth

1.8%

Cash Flow

5/5

Trend

Stable

Evidence

Positive free cash flow · 3.1Consistent free cash flow · 5/5Reasonable earnings multiple · 12.54High debt level · 2.17Weak profitability

Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$16.51

Change-0.09%

Shares Out123.51M

Market Cap$2.04B

Enterprise Value$4.07B

52W Range11.65 - 16.99

Beta0.79

P/E15.28

P/S0.37

P/B1.16

P/FCF17.40

EV/Sales0.74

Price$16.51

Change-0.09%

Shares Out123.51M

Market Cap$2.04B

Enterprise Value$4.07B

52W Range11.65 - 16.99

Beta0.79

P/E15.28

P/S0.37

P/B1.16

P/FCF17.40

EV/Sales0.74

EV/EBITDA8.04

EV/FCF34.75

Earnings Yield6.54%

FCF Yield5.75%

Dividend Yield1.54%

Gross Margin11.54%

Oper. Margin6.14%

Profit Margin2.68%

Debt/Eq2.17

Current Ratio1.04

Quick Ratio1.04

Revenue 5Y1.83%

Target$16.50

Target Upside-0.06%

Target Median$16.50

Target Range16.50 - 16.50

Volume14.27M

Avg Volume2.28M

EPS Surprise-0.07

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

29/100

Financial Strength

Debt, cash, stability

42/100

Growth Potential

Revenue and expansion

58/100

Price Attractiveness

Cheap or expensive today

90/100

Why this score▼

Positive free cash flow · 3.1Consistent free cash flow · 5/5Reasonable earnings multiple · 12.54High debt level · 2.17Weak profitability

Analyst view

Analyst sentiment and price target

SEM

Analyst sentiment

Based on 14 analyst votes · 2026-09-04

64/100

Neutral

Bullish

Hold

Bearish

Price Target

2026-07-31

Low

$16.50

Mean

$17.75

Median

$17.75

High

$19.00

Company Overview

IPO: 9/25/2009

Industry: Medical - Care Facilities

P/B i: 1.16

Debt / Equity i: 2.17

Operating Margin: 6.14%

Net Margin: 2.68%

ROE i: -

ROIC: -

Financial Health

Score8 / 20

Debt / Equity: 2.17

Current Ratio: 1.04

Quick Ratio: 1.04

Status: Moderate

Warnings

High debt level

Insider Transactions

Recent executive and insider activity

⚠ 12 high-volume insider sells detected

Breighner Robert G. JR

Transaction: 06/30/2026

SELL

Change

-18,362

Price

$16.50

Filing

07/01/2026

Type

SELL

CARSON RUSSELL L

Transaction: 06/30/2026

SELL

Change

-610,035

Price

Not reported

Filing

07/01/2026

Type

SELL

ORTENZIO ROBERT A

Transaction: 06/30/2026

SELL

Change

-279,000

Price

$16.50

Filing

07/01/2026

Type

SELL

Insider	Type	Change	Price	Transaction	Filing
Breighner Robert G. JR	SELL	-18,362	$16.50	06/30/2026	07/01/2026
CARSON RUSSELL L	SELL	-610,035	Not reported	06/30/2026	07/01/2026
ORTENZIO ROBERT A	SELL	-279,000	$16.50	06/30/2026	07/01/2026
JACKSON MARTIN F	SELL	-2,634	Not reported	06/30/2026	07/01/2026
Saich John A.	SELL	-736,412	Not reported	06/30/2026	07/01/2026
Mullin Thomas P	SELL	-391,709	Not reported	06/30/2026	07/01/2026
Rusignuolo Brian R.	SELL	-361,370	Not reported	06/30/2026	07/01/2026
Malatesta Michael F	SELL	-238,057	Not reported	06/30/2026	07/01/2026
Weigl Christopher	SELL	-1,872	$16.50	06/30/2026	07/01/2026
CHERNOW DAVID S	SELL	-113,421	$16.50	06/30/2026	07/01/2026
Hollenbach John Tyler	SELL	-135,084	Not reported	06/30/2026	07/01/2026
Duggan John F.	SELL	-194,710	Not reported	06/30/2026	07/01/2026
Ely James S. III	SELL	-161,674	$16.50	06/30/2026	07/01/2026
Khanuja Parvinderjit S.	SELL	-79,124	$16.50	06/30/2026	07/01/2026
Thomas Daniel	SELL	-80,035	$16.50	06/30/2026	07/01/2026
TAVENNER MARILYN B	SELL	-36,035	$16.50	06/30/2026	07/01/2026
Frist William H.	SELL	-306,266	$16.50	06/30/2026	07/01/2026
Davisson Katherine R	SELL	-60,035	$16.50	06/30/2026	07/01/2026
Scully Thomas	SELL	-103,424	$16.50	06/30/2026	07/01/2026
Breighner Robert G. JR	SELL	-1,330	$16.44	05/04/2026	05/05/2026

About the Company

Select Medical Holdings Corporation

Select Medical Holdings Corporation (SEM) is a U.S.-based healthcare organization that manages a diverse portfolio of specialized medical facilities. The company operates across four primary divisions: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers. Its Critical Illness Recovery Hospital division focuses on patients with severe and complex medical conditions, such as heart failure, infectious diseases, respiratory failure, renal issues, neurological events, and trauma requiring extended recovery. The Rehabilitation Hospital division delivers therapeutic and rehabilitative care for conditions including brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic challenges, pediatric disabilities, and cancer. The Outpatient Rehabilitation division comprises clinics offering physical, occupational, and speech therapy, alongside specialized programs for work-related injuries, hand therapy, post-concussion recovery, pediatric and cancer rehabilitation, and athletic training. Lastly, the Concentra division provides occupational medicine, consumer health, physical therapy, and wellness services through its occupational health centers and contract services located at employer worksites. As of December 31, 2021, Select Medical's extensive network included 104 critical illness recovery hospitals spanning 28 states, 30 rehabilitation hospitals across 12 states, 1,881 outpatient rehabilitation clinics in 38 states and D.C., 518 occupational health centers in 41 states, and 134 on-site clinics at employer locations. Founded in 1996, the company maintains its headquarters in Mechanicsburg, Pennsylvania.

Source - link

Peers

ACHC ARDT ASTH AVAH HCSG HRMY LFST MD NHC USPH

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Select Medical Holdings Corporation Acquired by Consortium Led by Robert A. Ortenzio, Martin F.

MECHANICSBURG, Pa., June 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (the "Company" or "Select Medical," "we," "us," or "our") (NYSE: SEM) today announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A.

PRNewsWire

Select Medical Holdings Corporation Announces Stockholder Approval of Acquisition by Consortium Led by Robert A. Ortenzio, Martin F.

MECHANICSBURG, Pa., June 26, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and Plan of Merger (the "Merger Agreement," and the transaction contemplated thereby, the "Merger") with an entity affiliated with a consortium led by Robert A.

PRNewsWire

$SEM Investigation Notice: BFA Law is Investigating the Select Medical Board for Breaching its Duties to Shareholders after $16.50 Acquisition Announced

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire

SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition – Current Shareholders Urged to Contact BFA Law

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

GlobeNewsWire

Are BCO, SEM, NATL Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

PRNewsWire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-04-30	0.43	0.36	-0.07
2026-02-19	0.23	0.16	-0.07
2025-10-30	0.18	0.23	0.05
2025-07-31	0.28	0.32	0.04
2025-05-01	0.45	0.44	-0.01
2025-02-20	0.29	0.18	-0.11
2024-10-31	0.43	0.43	0
2024-08-01	0.61	0.6	-0.01
2024-05-02	0.57	0.75	0.18
2024-02-22	0.36	0.36	0
2023-11-02	0.41	0.46	0.05
2023-08-03	0.48	0.61	0.13